Here’s How To Keep Counterfeiters From Duplicating Your Marijuana Products

Flav packaging includes a tamper-resistant hologram seal and QR code from AuthentiBrand (Photo courtesy of Flav)

(This is an abridged version of a story that appears in the April issue of Marijuana Business Magazine.)

For years, counterfeiters have been creating and selling knockoffs of Rolex watches, Louis Vuitton handbags and Ray Ban sunglasses.

Now, it’s the marijuana industry’s turn.

Counterfeiters seeking to exploit the marijuana sector’s explosive growth are increasingly targeting knocking off cannabis products.

As a result, cannabis companies have stepped up their efforts to guard their products through such measures as trademarking or keeping closer tabs on their supply chains.

Counterfeiters are especially interested in disposable vape cartridges and are making knockoff versions of well-known brand names and logos that include Heavy Hitters, Brass Knuckles and Kingpen, to name a few.

But cannabis forgers are also taking stabs at imitating packaged marijuana flower products such as Canndescent, according to a recent report by California-based Mammoth Distribution.

How wide spread is the situation? Some attendees at MJBizCon in Las Vegas last November found knockoffs of their own products on the expo show floor.

“I had a half-dozen companies approach me at (MJBizCon), telling me that they had seen product that appeared to be theirs but was actually counterfeit,” said Peter Scheir, whose company, California-based AuthentiBrand, offers custom hologram and authentication solutions to various industries to help combat cheap imitations.

“I was flabbergasted, because … this is someone who had the gumption to walk into a major trade show and show it.

“To me, that could mean that the companies presenting the product didn’t even know they were counterfeit, or that they were colossally stupid or at least callous.”

Scheir and other experts shared some tips with Marijuana Business Magazine about how cannabis companies can protect themselves and their brands. Just click on the links below:

Original Article Source: https://mjbizdaily.com/how-to-keep-counterfeiters-from-duplicating-your-marijuana-products/

Comments

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...

Can Medical Marijuana Help Aging Parents With Dementia?

For decades, marijuana, even for medical uses, was demonized or questioned. When states like Colorado legalized it for recreational use, more studies began to determine provable efficacy for its use as a medicine. The Federal government still classifies marijuana the same way it classifies heroin: harmful and with no medical benefits. Now we can see that this is wrong. When states legalized marijuana, referred to as cannabis here, they had an interest in getting data to see what good it could do. Proving efficacy could increase medical marijuana sales, benefit people who might at least find some medical use, and overall would bring tax dollars into the state coffers. Without funding studies, the Federal government has done very little to demonstrate what good cannabis can do. After all, if the presumption is that it helps nothing, there would be no motivation to determine with scientific data that it does anyone any good. But we have convincing data now about its beneficial use ...

Norma Pence

Search This Blog